Showing results (1791-1800 of 1,837) with videos related to
Sort By:
Pageof 184
Nature Genetics|March 12, 2014
Mutations in TJP2 cause progressive cholestatic liver diseaseMelissa Sambrotta, Sandra Strautnieks, Efterpi Papouli, et al.Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Tracking Cytopenias in FANCA-deficient Fanconi AnemiaRochelle R Maxwell, Tamar Berger, Caroline S Jiang, et al.Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.BMC Ecology|March 22, 2016
Skeletal light-scattering accelerates bleaching response in reef-building coralsTimothy D Swain, Emily DuBois, Andrew Gomes, et al.Leukemia|January 17, 2017
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCTM Neuenhahn, J Albrecht, M Odendahl, et al.Bone Marrow Transplantation|March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromesR Martino, A Henseler, M van Lint, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcomeMichael B Tomblyn, Mukta Arora, K Scott Baker, et al.Elife|May 30, 2019
Club cells form lung adenocarcinomas and maintain the alveoli of adult miceMagda Spella, Ioannis Lilis, Mario Aa Pepe, et al.The European Respiratory Journal|June 27, 2024
An electrocardiogram-based AI algorithm for early detection of pulmonary hypertensionHilary M DuBrock, Tyler E Wagner, Katherine Carlson, et al.Journal for Immunotherapy of Cancer|August 3, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysisElizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, et al.Pageof 184